Intralipid (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the Intralipid drug offered from Baxter Healthcare Corporation. This Lipid Emulsion [EPC],Lipids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: SOYBEAN OIL
SUBSTANCE NAME: SOYBEAN OIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Lipid Emulsion [EPC],Lipids [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: EMULSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2004-04-01
END MARKETING DATE: 0000-00-00


Intralipid HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIntralipid from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 20(g/100mL)
START MARKETING DATE: 2004-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0338-0519_a32b806c-59e2-4c5a-bd65-305edc8ec7d0
PRODUCT NDC: 0338-0519
APPLICATION NUMBER: NDA020248

Other SOYBEAN OIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AMI Cosmetic Co.,Ltd.essenHERB Soybean 90 Deep Cleansing
B. Braun Medical Inc.NutriLipid I.V. Fat Emulsion
Baxter Healthcare CORPIntralipid
Baxter Healthcare CorporationIntralipid